CIK 0001159036 · Large accelerated filer
HALOZYME THERAPEUTICS, INC.
Sign in to watch- Ticker
- HALO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 880488686
- Phone
- (858) 794-8889
- Business address
- 12390 EL CAMINO REAL, SAN DIEGO, CA, 92130
- Former names
- HALOZYME THERAPEUTICS INC, GLOBAL YACHT SERVICES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $19,884,955
- in 5 filings, $19.9M under 10b5-1 plans
Net −$19,884,955. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-09-26 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −10,000 | $56.10 | $561K | 676,744 |
| 2024-09-26 | Torley Helen PRESIDENT AND CEO | Option exercise · Option to Purchase Common Stock 10b5-1 | −10,000 | $13.87 | $139K | 20,000 |
| 2024-09-25 | Torley Helen PRESIDENT AND CEO | Option exercise 10b5-1 | +10,000 | $13.87 | $139K | 686,744 |
| 2024-09-25 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −10,000 | $56.34 | $563K | 676,744 |
| 2024-09-25 | Torley Helen PRESIDENT AND CEO | Option exercise · Option to Purchase Common Stock 10b5-1 | −10,000 | $13.87 | $139K | 30,000 |
| 2024-09-24 | Torley Helen PRESIDENT AND CEO | Option exercise 10b5-1 | +10,000 | $13.87 | $139K | 686,744 |
| 2024-09-24 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −10,000 | $58.21 | $582K | 676,744 |
| 2024-09-24 | Torley Helen PRESIDENT AND CEO | Option exercise · Option to Purchase Common Stock 10b5-1 | −10,000 | $13.87 | $139K | 40,000 |
| 2024-09-18 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Option exercise 10b5-1 | +10,000 | $16.65 | $167K | 183,756 |
| 2024-09-18 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Sale 10b5-1 | −7,963 | $61.89 | $493K | 175,793 |
| 2024-09-18 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Sale 10b5-1 | −2,037 | $62.58 | $127K | 173,756 |
| 2024-09-18 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Option exercise · Option to Purchase Common Stock 10b5-1 | −10,000 | 11,861 | ||
| 2024-09-17 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Option exercise 10b5-1 | +10,000 | $16.65 | $167K | 183,756 |
| 2024-09-17 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Sale 10b5-1 | −10,000 | $62.88 | $629K | 173,756 |
| 2024-09-17 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Option exercise · Option to Purchase Common Stock 10b5-1 | −10,000 | 21,861 | ||
| 2024-09-12 | Torley Helen PRESIDENT AND CEO | Option exercise 10b5-1 | +10,000 | $13.87 | $139K | 686,744 |
| 2024-09-12 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −10,000 | $59.20 | $592K | 676,744 |
| 2024-09-12 | Torley Helen PRESIDENT AND CEO | Option exercise · Option to Purchase Common Stock 10b5-1 | −10,000 | $13.87 | $139K | 50,000 |
| 2024-09-11 | Torley Helen PRESIDENT AND CEO | Option exercise 10b5-1 | +10,000 | $13.87 | $139K | 686,744 |
| 2024-09-11 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −10,000 | $59.09 | $591K | 676,744 |
Page 25 of 26 · 513 trades